Citations

Showing 10 of 108083 citations.

Opioid Use Disorder from Poppy Seed Tea Use: A Case Report
Kauppila, Glenn , Eagen, Kellene , Kauppila, Glenn R, Eagen, Kellene V

Mayo Clinic

American Journal of Case Reports | January 9, 2023 | Volume: 24 | Issue: No issue available | Pages: No page available

10.12659/ajcr.938675 | PMID 36698302 Get It

Transoral Outlet Reduction (TORe) for the Treatment of Weight Regain and Dumping Syndrome after Roux-en-Y Gastric Bypass
Hakiza, Landry , Sartoretto, Adrian , Burgmann, Konstantin, Kumbhari, Vivek , Matter, Christoph, Seibold, Frank , Staudenmann, Dominic

Mayo Clinic

Medicina | January 9, 2023 | Volume: 59 | Issue: 1 | Pages: 125

10.3390/medicina59010125 | PMID 36676749 Get It

Obesity is a chronic relapsing disease of global pandemic proportions. In this context, an increasing number of patients are undergoing bariatric surgery, which is considered the most effective weight loss treatment for long-term improvement in obesity-related comorbidities. One of the most popular bariatric surgeries is the Roux-en-Y gastric bypass (RYGB). Despite its proven short- and long-term efficacy, progressive weight regain and dumping symptoms remain a challenge. Revisional bariatric surgery is indicated when dietary and lifestyle modification, pharmaceutical agents and/or psychological therapy fail to arrest weight regain or control dumping. However, these re-interventions present greater technical difficulty and are accompanied by an increased risk of peri- and postoperative complications with substantial morbidity and mortality. The endoscopic approach to gastrojejunal anastomotic revision, transoral outlet reduction (TORe), is used as a minimally invasive treatment that aims to reduce the diameter of the gastrojejunal anastomosis, delaying gastric emptying and increasing satiety. With substantial published data supporting its use, TORe is an effective and safe bariatric endoscopic technique for addressing weight regain and dumping syndrome after RYGB.
No “July Effect” in the management and outcomes of acute myocardial infarction: An 18‐year United States national study
Patlolla, Sri Harsha , Truesdell, Alexander G. , Basir, Mir B. , Rab, S. Tanveer , Singh, Mandeep , Belford, P. Matthew , Zhao, David , Vallabhajosyula, Saraschandra , Rab, Syed T , Zhao, David X , Vallabhajosyula, Saraschandra , Harsha Patlolla, Sri

Mayo Clinic

Catheterization and Cardiovascular Interventions | January 8, 2023 | Volume: 101 | Issue: 2 | Pages: 264-273

10.1002/ccd.30553 | PMID 36617382 Get It

AbstractBackgroundThere has been conflicting reports on the effect of new trainees on clinical outcomes at teaching hospitals in the first training month (July in the United States of America). We sought to assess this “July effect” in a contemporary acute myocardial infarction (AMI) population.MethodsAdult (>18 years) AMI hospitalizations in May and July in urban teaching and urban nonteaching hospitals in the United States were identified from the HCUP‐NIS database (2000–2017). In‐hospital mortality was compared between May and July admissions. A difference‐in‐difference analysis comparing a change in outcome from May to July in teaching hospitals to a change in outcome from May to July in nonteaching hospitals was also performed.ResultsA total of 1,312,006 AMI hospitalizations from urban teaching (n = 710,593; 54.2%) or nonteaching (n = 601,413; 45.8%) hospitals in the months of May and July were evaluated. May admissions in teaching hospitals, had greater comorbidity, higher rates of acute multiorgan failure (10.6% vs. 10.2%, p < 0.001) and lower rates of cardiac arrest when compared to July admissions. July AMI admissions had lower in‐hospital mortality compared to May (5.6% vs. 5.8%; adjusted odds ratio 0.94 [95% confidence interval 0.92–0.97]; p < 0.001) in teaching hospitals. Using the difference‐in‐difference model, there was no evidence of a July effect for in‐hospital mortality (p = 0.19).ConclusionsThere was no July effect for in‐hospital mortality in this contemporary AMI population.
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients
Cardozo, Licy L. Yanes , Takahashi, Paul Y. , Larson, Nicholas B. , Castillo, Alexandra , Podwika, Alana, Filippis, Eleanna De , Hernandez, Valentina, Mahajan, Gouri , Gonzalez, Crystal, Shubhangi, Shubhangi, Decker, Paul A. , Killian, Jill M. , Shah, Pankaj, Ryu, Euijung , Marshall, Gailen D. , Summers, Richard L., Bielinski, Suzette , Yanes Cardozo, Licy L , Takahashi, Paul , Larson, Nicholas B , De Filippis, Eleanna, Decker, Paul A. , Killian, Jill M , Olson, Janet E , St Sauver, Jennifer L , Vella, Adrian , Ryu, Euijung , Liu, Hongfang , Cerhan, James R , Bielinski, Suzette J. , Olson, Janet E. , Sauver, Jennifer L. St. , Shah, Pankaj, Vella, Adrian , Liu, Hongfang , Cerhan, James R. , Singh, Davinder

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 8, 2023 | Volume: 108 | Issue: 7 | Pages: 1740-1746

10.1210/clinem/dgac759 | PMID 36617249 Get It

Abstract Context Metformin is the first-line drug for treating diabetes but has a high failure rate. Objective To identify demographic and clinical factors available in the electronic health record (EHR) that predict metformin failure. Methods A cohort of patients with at least 1 abnormal diabetes screening test that initiated metformin was identified at 3 sites (Arizona, Mississippi, and Minnesota). We identified 22 047 metformin initiators (48% female, mean age of 57 ± 14 years) including 2141 African Americans, 440 Asians, 962 Other/Multiracial, 1539 Hispanics, and 16 764 non-Hispanic White people. We defined metformin failure as either the lack of a target glycated hemoglobin (HbA1c) (&lt;7%) within 18 months of index or the start of dual therapy. We used tree-based extreme gradient boosting (XGBoost) models to assess overall risk prediction performance and relative contribution of individual factors when using EHR data for risk of metformin failure. Results In this large diverse population, we observed a high rate of metformin failure (43%). The XGBoost model that included baseline HbA1c, age, sex, and race/ethnicity corresponded to high discrimination performance (C-index of 0.731; 95% CI 0.722, 0.740) for risk of metformin failure. Baseline HbA1c corresponded to the largest feature performance with higher levels associated with metformin failure. The addition of other clinical factors improved model performance (0.745; 95% CI 0.737, 0.754, P &lt; .0001). Conclusion Baseline HbA1c was the strongest predictor of metformin failure and additional factors substantially improved performance suggesting that routinely available clinical data could be used to identify patients at high risk of metformin failure who might benefit from closer monitoring and earlier treatment intensification.
Implementation and expansion of inpatient and ambulatory pharmacist credentialing and privileging at an academic medical center
Dawson, Courtney , Pham, Aaron N., Shipman, Colleen J., Lau, G., Pham, Yen T, Dawson, Courtney, Lau, Gary

Mayo Clinic

American Journal of Health-System Pharmacy | January 8, 2023 | Volume: 80 | Issue: 12 | Pages: 756-764

10.1093/ajhp/zxad005 | PMID 36617182 Get It

Abstract Purpose This article highlights one academic medical center’s effort to implement a complete credentialing and privileging (C&P) process for both inpatient and ambulatory clinical pharmacists. Summary The C&P process offers a recognized method to advance pharmacy practice. Credentialing is defined as a process whereby an individual is deemed qualified in a specific subject matter area. Privileging is the process whereby an institution grants authority to an individual to perform services based on credentials. Federal guidelines permit pharmacists to obtain the same level of privileges as professional medical staff, such as physicians, if relevant state laws allow for the corresponding pharmacist scope of practice. States establish laws and regulations that specify the scope of practice for various types of licensed healthcare professionals, including pharmacists. Many health systems have attempted pharmacist C&P practices in both the inpatient and ambulatory care setting with varying degrees of success and reach. Privileged pharmacists provide established benefits and value to other members of the healthcare team. Oregon Health & Science University (OHSU) pursued C&P for both inpatient and ambulatory clinical pharmacists. Initiation and implementation processes were complex and accompanied by a variety of challenges. Conclusion OHSU operates with advanced pharmacy practice integrated into the interdisciplinary patient care team. Pharmacist C&P allows pharmacists to demonstrate significant clinical benefits and quality improvement in patient care delivery in both inpatient and ambulatory settings.
Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
Juran, Brian D., Ali, Ahmad H. , Schlicht, Erik M., Bianchi, Jackie K., Hu, Xin , Liang, Yongliang , Liu, Ken , Go, Young‐Mi , Folseraas, Trine , Karlsen, Tom H. , Athreya, Arjun P. , Grant, Caroline W. , Ali, Ahmad H , Go, Young-Mi , Miller, Gary W. , Lazaridis, Konstantinos N , Jarrell, Zachery Ryan , Jones, Dean P. , Walker, Douglas Ian , LaRusso, Nicholas F. , Gores, Gregory J. , Lazaridis, Konstantinos N.

Mayo Clinic

Exposome | January 8, 2023 | Volume: 3 | Issue: 1 | Pages: No page available

10.1093/exposome/osac011 | PMID 36687160 Get It

Abstract Primary sclerosing cholangitis (PSC) is a complex bile duct disorder. Its etiology is incompletely understood, but environmental chemicals likely contribute to risk. Patients with PSC have an altered bile metabolome, which may be influenced by environmental chemicals. This novel study utilized state-of-the-art high-resolution mass spectrometry (HRMS) with bile samples to provide the first characterization of environmental chemicals and metabolomics (collectively, the exposome) in PSC patients located in the United States of America (USA) (n = 24) and Norway (n = 30). First, environmental chemical- and metabolome-wide association studies were conducted to assess geographic-based similarities and differences in the bile of PSC patients. Nine environmental chemicals (false discovery rate, FDR &lt; 0.20) and 3143 metabolic features (FDR &lt; 0.05) differed by site. Next, pathway analysis was performed to identify metabolomic pathways that were similarly and differentially enriched by the site. Fifteen pathways were differentially enriched (P &lt; .05) in the categories of amino acid, glycan, carbohydrate, energy, and vitamin/cofactor metabolism. Finally, chemicals and pathways were integrated to derive exposure–effect correlation networks by site. These networks demonstrate the shared and differential chemical–metabolome associations by site and highlight important pathways that are likely relevant to PSC. The USA patients demonstrated higher environmental chemical bile content and increased associations between chemicals and metabolic pathways than those in Norway. Polychlorinated biphenyl (PCB)-118 and PCB-101 were identified as chemicals of interest for additional investigation in PSC given broad associations with metabolomic pathways in both the USA and Norway patients. Associated pathways include glycan degradation pathways, which play a key role in microbiome regulation and thus may be implicated in PSC pathophysiology.
Cybersecurity and Information Assurance for the Clinical Laboratory
Patel, Ankush , Hart, Steven N. , Garcia, Christopher A., Durant, Thomas J S , Cornish, Toby C. , McClintock, David S. , Patel, Ankush U, Hart, Steven N , Cornish, Toby C , McClintock, David S , Patel, Ankush U , Williams, Christopher L

Mayo Clinic

The Journal of Applied Laboratory Medicine | January 7, 2023 | Volume: 8 | Issue: 1 | Pages: 145-161

10.1093/jalm/jfac119 | PMID 36610432 Get It

Abstract Background Network-connected medical devices have rapidly proliferated in the wake of recent global catalysts, leaving clinical laboratories and healthcare organizations vulnerable to malicious actors seeking to ransom sensitive healthcare information. As organizations become increasingly dependent on integrated systems and data-driven patient care operations, a sudden cyberattack and the associated downtime can have a devastating impact on patient care and the institution as a whole. Cybersecurity, information security, and information assurance principles are, therefore, vital for clinical laboratories to fully prepare for what has now become inevitable, future cyberattacks. Content This review aims to provide a basic understanding of cybersecurity, information security, and information assurance principles as they relate to healthcare and the clinical laboratories. Common cybersecurity risks and threats are defined in addition to current proactive and reactive cybersecurity controls. Information assurance strategies are reviewed, including traditional castle-and-moat and zero-trust security models. Finally, ways in which clinical laboratories can prepare for an eventual cyberattack with extended downtime are discussed. Summary The future of healthcare is intimately tied to technology, interoperability, and data to deliver the highest quality of patient care. Understanding cybersecurity and information assurance is just the first preparative step for clinical laboratories as they ensure the protection of patient data and the continuity of their operations.
Foreseeing Alcohol-Associated Liver Disease through Proteomic Biomarkers
Daniel, P. Vineeth , Malhi, Harmeet , Malhi, Harmeet , Daniel, P Vineeth

Mayo Clinic

Clinical Chemistry | January 7, 2023 | Volume: 69 | Issue: 5 | Pages: 438-441

10.1093/clinchem/hvac177 | PMID 36609503 Get It

Author response to: Comment on: Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies
Ghanem, Omar M. , Portela, Ray , Clapp, Benjamin

Mayo Clinic

British Journal of Surgery | January 7, 2023 | Volume: 110 | Issue: 3 | Pages: 388-388

10.1093/bjs/znac454 | PMID 36609560 Get It

Efficacy of personal protective equipment to prevent environmental infection of COVID-19 among healthcare workers: a systematic review
Soleman, Sani Rachman , Lyu, Zhaoqing , Sassa, Mariko Harada, Fujii, Yukiko , Mahmoud, Manal A. M. , Ebner, Daniel K. , Harada, Kouji H. , Harada, Kouji H , Okada, Takuya, Sassa, Mariko Harada

Mayo Clinic

Environmental Health and Preventive Medicine | January 6, 2023 | Volume: 28 | Pages: 1-1

10.1265/ehpm.22-00131 | PMID 36624079 Get It